Found: 247
Select item for more details and to access through your institution.
Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a european delphi consensus of the EARCO group.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02929-5
- By:
- Publication type:
- Article
Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case series.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Leveraging Computed Tomography Imaging to Detect Chronic Obstructive Pulmonary Disease and Concomitant Chronic Diseases.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 210, n. 3, p. 281, doi. 10.1164/rccm.202402-0407PP
- By:
- Publication type:
- Article
Genetic Epidemiology of Alpha-1 Antitrypsin Deficiency in Macaronesia.
- Published in:
- Respiration, 2024, v. 103, n. 7, p. 368, doi. 10.1159/000538293
- By:
- Publication type:
- Article
Motivation and Confidence about Physical Activity in Chronic Obstructive Pulmonary Disease Patients: Health Benefits Matter to Patients.
- Published in:
- Respiration, 2024, v. 103, n. 7, p. 378, doi. 10.1159/000539206
- By:
- Publication type:
- Article
Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.
- Published in:
- Respiratory Research, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12931-024-02879-y
- By:
- Publication type:
- Article
Detection of Alpha-1 Antitrypsin Levels in Chronic Obstructive Pulmonary Disease in Respiratory Clinics in Spain: Results of the EPOCONSUL 2021 Audit.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 955, doi. 10.3390/jcm13040955
- By:
- Publication type:
- Article
Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients.
- Published in:
- ERJ Open Research, 2024, v. 10, n. 1, p. 1, doi. 10.1183/23120541.00838-2023
- By:
- Publication type:
- Article
From treatable traits to GETomics in airway disease: moving towards clinical practice.
- Published in:
- European Respiratory Review, 2024, v. 33, n. 171, p. 1, doi. 10.1183/16000617.0143-2023
- By:
- Publication type:
- Article
Effects of a telerehabilitation program and detraining on cardiorespiratory fitness in patients with post‐COVID‐19 sequelae: A randomized controlled trial.
- Published in:
- Scandinavian Journal of Medicine & Science in Sports, 2024, v. 34, n. 1, p. 1, doi. 10.1111/sms.14543
- By:
- Publication type:
- Article
Effect of different types of supervised exercise programs on cardiorespiratory and muscular fitness, pain, fatigue, mental health and inflammatory and oxidative stress biomarkers in older patients with post-COVID-19 sequelae "EJerSA-COVID-19": a randomized controlled trial
- Published in:
- BMC Geriatrics, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12877-023-04544-3
- By:
- Publication type:
- Article
Nine controversial questions about augmentation therapy for alpha-1 antitrypsin deficiency: a viewpoint.
- Published in:
- European Respiratory Review, 2023, v. 32, n. 170, p. 1, doi. 10.1183/16000617.0170-2023
- By:
- Publication type:
- Article
Improving Outcomes of Chronic Obstructive Pulmonary Disease through the Treatment of Comorbidities: One Step Beyond.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Stepwise management of COPD: What is next after bronchodilation?
- Published in:
- Therapeutic Advances in Respiratory Disease, 2023, p. 1, doi. 10.1177/17534666231208630
- By:
- Publication type:
- Article
Poor sleep quality, COPD severity and survival according to CASIS and Pittsburgh questionnaires.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45717-9
- By:
- Publication type:
- Article
Implementing an Evidence-Based COPD Hospital Discharge Protocol: A Narrative Review and Expert Recommendations.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 10, p. 4236, doi. 10.1007/s12325-023-02609-8
- By:
- Publication type:
- Article
An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 4, p. 374, doi. 10.1164/rccm.202303-0400SO
- By:
- Publication type:
- Article
The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02830-2
- By:
- Publication type:
- Article
Smoking and COPD Knowledge in the General Spanish Population: A CONOCEPOC Study.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4473, doi. 10.3390/jcm12134473
- By:
- Publication type:
- Article
Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic network.
- Published in:
- Human Genomics, 2023, v. 17, n. 1, p. 1, doi. 10.1186/s40246-023-00497-1
- By:
- Publication type:
- Article
Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 2, p. 516, doi. 10.3390/biomedicines11020516
- By:
- Publication type:
- Article
COVID-19's impact on care practice for alpha-1-antitrypsin deficiency patients.
- Published in:
- BMC Health Services Research, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12913-023-09094-3
- By:
- Publication type:
- Article
Stepwise management of COPD: What is next after bronchodilation?
- Published in:
- Therapeutic Advances in Respiratory Disease, 2023, v. 17, p. 1, doi. 10.1177/17534666231208630
- By:
- Publication type:
- Article
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02275-4
- By:
- Publication type:
- Article
Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02268-3
- By:
- Publication type:
- Article
New variants of alpha-1-antitrypsin: structural simulations and clinical expression.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02271-8
- By:
- Publication type:
- Article
Impaired pulmonary and muscle function during moderate exercise in female patients recovered from SARS-CoV-2.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-24941-9
- By:
- Publication type:
- Article
Discriminant Validity of a Single Clinical Question for the Screening of Inactivity in Individuals Living with COPD.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 3033, doi. 10.2147/COPD.S378758
- By:
- Publication type:
- Article
LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 22, p. 6623, doi. 10.3390/jcm11226623
- By:
- Publication type:
- Article
Use of Computed Tomography Lung Densitometry as an Outcome Measure for Emphysema Progression: The Case of Losartan.
- Published in:
- 2022
- By:
- Publication type:
- editorial
Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 2187, doi. 10.2147/COPD.S378649
- By:
- Publication type:
- Article
Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD: A Cohort Sub-Study in a Randomized Trial Population.
- Published in:
- Biomedicines, 2022, v. 10, n. 8, p. N.PAG, doi. 10.3390/biomedicines10082011
- By:
- Publication type:
- Article
Pulmonologists' Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 1577, doi. 10.2147/COPD.S369118
- By:
- Publication type:
- Article
Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Diaphragmatic Movement at Rest and After Exertion: A Non-Invasive and Easy to Obtain Prognostic Marker in COPD.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 1041, doi. 10.2147/COPD.S361235
- By:
- Publication type:
- Article
Frequency and Associated Factors of Suicidal Ideation in Patients with Chronic Obstructive Pulmonary Disease.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2558, doi. 10.3390/jcm11092558
- By:
- Publication type:
- Article
Determinants in the Underdiagnosis of COPD in Spain—CONOCEPOC Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2670, doi. 10.3390/jcm11092670
- By:
- Publication type:
- Article
Characteristics and treatment patterns of patients with asthma on multiple-inhaler triple therapy in Spain.
- Published in:
- NPJ Primary Care Respiratory Medicine, 2022, v. 32, n. 1, p. 1, doi. 10.1038/s41533-022-00270-2
- By:
- Publication type:
- Article
Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews.
- Published in:
- European Respiratory Review, 2022, v. 31, n. 163, p. 1, doi. 10.1183/16000617.0262-2021
- By:
- Publication type:
- Article
A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 545, doi. 10.2147/COPD.S350167
- By:
- Publication type:
- Article
The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 621, doi. 10.2147/COPD.S357491
- By:
- Publication type:
- Article
Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 371, doi. 10.2147/COPD.S346294
- By:
- Publication type:
- Article
CONQUEST: A Quality Improvement Program for Defining and Optimizing Standards of Care for Modifiable High-Risk COPD Patients.
- Published in:
- Patient Related Outcome Measures, 2022, v. 13, p. 53, doi. 10.2147/PROM.S296506
- By:
- Publication type:
- Article
Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 53, doi. 10.2147/COPD.S346051
- By:
- Publication type:
- Article
Inhaled Corticosteroid Use Among COPD Patients in Primary Care in Spain.
- Published in:
- International Journal of COPD, 2022, v. 17, p. 245, doi. 10.2147/COPD.S342220
- By:
- Publication type:
- Article
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Economic Impact of Low Adherence to COPD Management Guidelines in Spain.
- Published in:
- International Journal of COPD, 2021, v. 16, p. 3131, doi. 10.2147/COPD.S322793
- By:
- Publication type:
- Article
Correction to: Association between circulating alpha-1 antitrypsin polymers and lung and liver disease.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice